homesearchcontact

new

q + a

testing

articles

books

experiences
newq + atestingarticlesbooksexperienceslinks
links
[Contents][Appendix 1]
[Reference 136][Reference 138]

E is for Ecstasy by Nicholas Saunders

Appendix 1: Reference Section

137 Phone conversation with Dr. George Ricaurte, 16/11/93

Dr. Ricaurte's paper on the 5 year trial comparing 30 MDMA users with controls has been accepted for publication provided he can show that his subjects were telling the truth, and list other drugs they were using. I asked whether the toxicity he found may also be caused by fluoxetine. He replied that the differences in action far outweighed the similarities - though they both lowered levels of serotonin, fluoxetine blocks its re-uptake rather than reducing its production. The only specific similarity is the long-term reduction in serotonin.

I also asked about fenfluramine. Dr. Ricaurte said that some brands consist of a mixture of isomers, one of which is believed to have similar toxicity to MDMA and another less toxic. The Lancet published an article about this toxicity and then published letters defending the supposedly toxic brand. Dr. Ricaurte believes the defensive letters were from people who have connections with the manufacturers.


[Contents][Appendix 1]
[Reference 136][Reference 138]
E is for Ecstasy by Nicholas Saunders (contact@ecstasy.org)
HTMLized by Lamont Granquist (lamontg@u.washington.edu)